Get started
222

MEDPACTO, INC.

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

235980 chart


Full chart

Key stats


Market capitalization
‪157.83 B‬ KRW
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−815 KRW
Net income (FY)
‪−35.32 B‬ KRW
Revenue (FY)
0.00 KRW
Shares float
‪24.75 M‬
Beta (1Y)
2.06

Employees


Employees (FY)
63
Change (1Y)
+1 +1.61%
Revenue / Employee (1Y)
0.00 KRW
Net income / Employee (1Y)
‪−430.63 K‬ KRW

About MEDPACTO, INC.


Sector
Health Technology
CEO
Seong-Jin Kim
Headquarters
Seoul
Website
medpacto.com
Founded
2013
ISIN
KR7235980000
FIGI
BBG00QT4TP96
MedPacto, Inc. researches and develops anti-cancer drugs. It engages in the development of therapeutic products to cure ulcer or neuropathy caused by diabetes. The company was founded by Seong-Jin Kim on June 19, 2013 and is headquartered in Seoul, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 235980 is 5,410 KRW — it has decreased by −0.84% in the past 24 hours. Watch MEDPACTO, INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange MEDPACTO, INC. stocks are traded under the ticker 235980.
235980 stock has risen by 2.96% compared to the previous week, the month change is a −22.31% fall, over the last year MEDPACTO, INC. has showed a −31.95% decrease.
235980 reached its all-time high on Sep 7, 2020 with the price of 114,585 KRW, and its all-time low was 4,420 KRW and was reached on Nov 15, 2024. View more price dynamics on 235980 chart.
See other stocks reaching their highest and lowest prices.
235980 stock is 27.24% volatile and has beta coefficient of 2.06. Track MEDPACTO, INC. stock price on the chart and check out the list of the most volatile stocks — is MEDPACTO, INC. there?
Today MEDPACTO, INC. has the market capitalization of ‪157.83 B‬, it has increased by 4.75% over the last week.
Yes, you can track MEDPACTO, INC. financials in yearly and quarterly reports right on TradingView.
235980 net income for the last quarter is ‪−1.75 B‬ KRW, while the quarter before that showed ‪−4.68 B‬ KRW of net income which accounts for 62.55% change. Track more MEDPACTO, INC. financial stats to get the full picture.
No, 235980 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 25, 2024, the company has 63.00 employees. See our rating of the largest employees — is MEDPACTO, INC. on this list?
Like other stocks, 235980 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDPACTO, INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDPACTO, INC. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDPACTO, INC. stock shows the sell signal. See more of MEDPACTO, INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.